IV vs Epidural Opioids + Epidural Local Anesthetic for Laparotomy Analgesia
Launched by UNIVERSITY OF IOWA · Aug 14, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different methods of giving pain relief after a major surgery called laparotomy, which involves making a large incision in the abdomen. The researchers want to find out if using opioids (a type of strong pain medicine) through an epidural (a method of delivering medicine into the lower back) is just as effective when mixed with local anesthetics versus when given through an IV (intravenously). The goal is to help patients manage their pain after surgery more effectively.
To join this study, participants need to be between 18 and 85 years old and scheduled for an open abdominal surgery where an epidural is usually offered. They must also be able to communicate in English and use a special pump to control their own pain medication. However, individuals with certain conditions, such as a history of substance abuse or specific medical issues, will not be eligible. Participants in the trial will receive either method of pain relief and will be monitored to see how well it works for managing their post-operative pain. This study is currently recruiting participants, so there is an opportunity to take part in important research that could improve pain management options after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age including and between 18 to 85 years old
- • 2. Planned open abdominal procedure with an incision that is or includes above the umbilicus, where epidural would normally be offered and epidural would be maintained for an average of 4 to 5 days
- • 3. Patient has consented for an epidural
- • 4. Patient is able to converse in English
- • 5. Patient is able to use a patient controlled pump
- Exclusion Criteria:
- • 1. Has a known contraindication for an epidural
- • 2. Known mental or cognitive disability
- • 3. History of chronic opioid use or substance abuse disorder
- • 4. Pre-operative use of opioids
- • 5. History of chronic pain
- • 6. Routine use of marijuana
- • 7. Incarcerated
- • 8. Unable to converse in English
- • 9. Planned to remain intubated post-operatively
- • 10. Need for post-operative use of anticoagulant regiment that would be contraindicated with an indwelling epidural catheter
- • 11. End stage renal disease or dialysis
- • 12. Hepatic disease that affects metabolism of drugs
- • 13. Known contraindication to any of the study drugs
- • 14. Known pregnancy or positive pre-operative pregnancy test
- • 15. Known neurological condition that may affect motor or sensory systems
About University Of Iowa
The University of Iowa, a leading academic and research institution, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and researchers to investigate cutting-edge therapies and treatments across various medical fields. Committed to ethical research practices and patient-centered care, the University of Iowa strives to contribute significantly to medical knowledge and improve health outcomes through rigorous scientific inquiry and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Patients applied
Trial Officials
Melinda Seering, MD
Principal Investigator
Univeristy of Iowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported